Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.45 - $5.04 $4,165 - $8,568
-1,700 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$4.5 - $11.91 $607 - $1,607
135 Added 8.63%
1,700 $8,000
Q3 2021

Nov 09, 2021

BUY
$8.52 - $24.77 $13,333 - $38,765
1,565 New
1,565 $14,000

Others Institutions Holding NRXP

About NRX Pharmaceuticals, Inc.


  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $111M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.